Monday, April 28, 2025

Latest

Trulieve Cannabis Sees CFO Quit After Just Ten Days On The Job

Trulieve Cannabis (CSE: TRUL) has seen its newly appointed chief financial officer resign from his role with the company. He held the post for just ten days.

Tim Mullany, who the company announced last month would be taking on the role of CFO following the sudden departure of Alex D’Amico on June 18, is now the second CFO to depart the company in the last month. Mullany took on the role effective July 10, and vacated it just ten days later on July 20 for personal reasons.

Mullany had agreed to be paid an annual salary of $550,000 for taking on the role, plus an annual bonus of up to 160% of his base salary based on certain achievements being met, an annual equity award of 58,666 restricted share units, and a long term equity incentive award worth $2.0 million at the time of signing. He reportedly did not receive any severance with his departure.

With Mullany out, Ryan Blust, VP of Finance for Trulieve, is back in the role of interim chief financial officer, a role he served during the period between D’Amico’s departure and Mullany’s start date.

Trulieve meanwhile is now again searching for a permanent chief financial officer, and has engaged an executive recruitment firm to assist in the search.

Trulieve Cannabis last traded at $5.51 on the CSE.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Bell Q3 Earnings: Massive Impairments. Guidance Cuts. A Mess.

Alamos Gold Q3: Record Revenue & Production Amid Rising Costs

The Junior Mining Market Is Back

Recommended

Germany Looks To Modernize Military Recruitment But Stops Short of Conscription

First Majestic Silver Posts Topline Revenue Of $146.1 Million In Q3 2024

Related News

Trulieve’s Q3 2024 Loss Jumps 137% Amid Push for Florida Legalization

Trulieve Cannabis Corp. (CSE: TRUL) released its third-quarter earnings report today, presenting financial data that...

Tuesday, November 5, 2024, 03:04:00 PM

Trulieve Sees HSR Act Waiting Period Lapse In Relation To Harvest Health Acquisition

Trulieve Cannabis (CSE: TRUL) is one step closer to acquiring that of Harvest Health and...

Tuesday, June 22, 2021, 07:19:35 AM

Stifel Reinitiates Coverage On Eight Cannabis Operators

Earlier this week, Stifel released a new report on cannabis operations, focused predominantly on US-based...

Friday, July 24, 2020, 03:30:00 PM

Trulieve Cannabis: Second Quarter 2021 Analyst Consensus Estimates

Trulieve Cannabis (CSE: TRUL) announced that they will be reporting their second quarter financials before...

Monday, August 9, 2021, 11:32:00 AM

Trulieve Repurchases $57.0 Million In Face Value Notes Despite Cash Constraints

Trulieve Cannabis (CSE: TRUL) revealed in a filing last night that it is using the...

Friday, September 22, 2023, 10:42:23 AM